Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of genus Epimedium in the treatment of osteoarthritis and relevant signaling pathways. | Chin Med | 2023 | 37525296 | PubTator, text mining | PubMed |
| The mechanism by which Naru 3 pill protects against intervertebral disc cartilage endplate degeneration based on network pharmacology and experimental verification. | J Orthop Surg Res | 2023 | 37525208 | PubTator, text mining | PubMed |
| In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions. | Hum Gene (Amst) | 2023 | 37521006 | PubTator, text mining | PubMed |
| Crosstalk between ferroptosis and chondrocytes in osteoarthritis: a systematic review of in vivo and in vitro studies. | Front Immunol | 2023 | 37520558 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cells-Derived Extracellular Vesicles as Potential Treatments for Osteoarthritis. | Pharmaceutics | 2023 | 37514001 | PubTator, text mining | PubMed |
| Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions. | Life (Basel) | 2023 | 37511835 | PubTator, text mining | PubMed |
| The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis. | Int J Mol Sci | 2023 | 37511413 | PubTator, text mining | PubMed |
| Low-Dose Non-Targeted Effects and Mitochondrial Control. | Int J Mol Sci | 2023 | 37511215 | PubTator, text mining | PubMed |
| Aberrant AHRR, ADAMTS2 and FAM184 DNA Methylation: Candidate Biomarkers in the Oral Rinse of Heavy Smokers. | Biomedicines | 2023 | 37509437 | PubTator, text mining | PubMed |
| Epigenetic Modifications of MiRNAs in Osteoarthritis: A Systematic Review on Their Methylation Levels and Effects on Chondrocytes, Extracellular Matrix and Joint Inflammation. | Cells | 2023 | 37508486 | PubTator, text mining | PubMed |
| Astaxanthin as a Potent Antioxidant for Promoting Bone Health: An Up-to-Date Review. | Antioxidants (Basel) | 2023 | 37508018 | PubTator, text mining | PubMed |
| A single nuclei atlas of aging human abdominal subcutaneous white adipose tissue. | Res Sq | 2023 | 37503028 | PubTator, text mining | PubMed |
| Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity. | Front Med (Lausanne) | 2023 | 37502362 | PubTator, text mining | PubMed |
| TAF15 regulates the BRD4/GREM1 axis and activates the gremlin-1-NF-κB pathway to promote OA progression. | Regen Ther | 2023 | 37496731 | PubTator, text mining | PubMed |
| Effects of synovial macrophages in osteoarthritis. | Front Immunol | 2023 | 37492583 | PubTator, text mining | PubMed |
| ADAMTS5 promotes neovascularization via autophagic degradation of PEDF in proliferative diabetic retinopathy. | Exp Eye Res | 2023 | 37490993 | PubTator, text mining | PubMed |
| The role of fibromodulin in inflammatory responses and diseases associated with inflammation. | Front Immunol | 2023 | 37483637 | PubTator, text mining | PubMed |
| MicroRNA-15a/β1,4-GalT-I axis contributes to cartilage degeneration via NF-κB signaling in osteoarthritis. | Clinics (Sao Paulo) | 2023 | 37478628 | PubTator, text mining | PubMed |
| Investigating the association between serum ADAM/ADAMTS levels and bone mineral density by mendelian randomization study. | BMC Genomics | 2023 | 37468870 | PubTator, text mining | PubMed |
| NEAT1-mediated miR-150-5p downregulation regulates b-catenin expression in OA chondrocytes. | Funct Integr Genomics | 2023 | 37468759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=19